Exagen Announces Publication of Two Key Studies Validating Clinical Performance of AVISE® Lupus in Patients with Probable SLE and Demonstrating Superior Clinical Utility Compared to Standard Diagnostic Testing


You May Also Like

Biogen Appoints Daniel Karp as EVP, Corporate Development

Seasoned executive brings strong track record of success leading licensing and M&A transactionsCAMBRIDGE, Mass., ...

Inovio Pharmaceuticals to Report Second Quarter 2017 Financial Results on August 8, 2017

PLYMOUTH MEETING, Pa., July 26, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced ...